Spots Global Cancer Trial Database for anaplastic oligoastrocytoma
Every month we try and update this database with for anaplastic oligoastrocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma | NCT02168270 | Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma Gliosarcoma | ascorbic acid temozolomide quality-of-life... laboratory biom... | 19 Years - | University of Nebraska | |
| Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors | NCT00303849 | Anaplastic Olig... Anaplastic Olig... Mixed Glioma Oligoastrocytom... | Carboplatin Etoposide Etoposide Phosp... Laboratory Biom... Mannitol Melphalan Quality-of-Life... Sodium Thiosulf... | 18 Years - 75 Years | OHSU Knight Cancer Institute | |
| A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma | NCT02026271 | Glioblastoma Mu... Anaplastic Olig... | Ad-RTS-hIL-12 veledimex | 18 Years - 75 Years | Alaunos Therapeutics | |
| Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas | NCT02795364 | Glioma Anaplastic Olig... Glioblastomas (... | Structural Imag... Metabolic Image... | 18 Years - 70 Years | Huashan Hospital | |
| Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma | NCT03072134 | Glioma Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma Mu... Astrocytoma, Gr... Astrocytoma, Gr... Brain Cancer | Neural stem cel... | 18 Years - | Northwestern University | |
| Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols | NCT00035373 | Glioblatoma Gliosarcoma Anaplastic Astr... Oligodendroglio... Anaplastic Olig... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma | NCT02168270 | Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma Gliosarcoma | ascorbic acid temozolomide quality-of-life... laboratory biom... | 19 Years - | University of Nebraska | |
| Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I | NCT00671801 | Malignant Gliom... | Irinotecan Lenalidomide | 18 Years - | M.D. Anderson Cancer Center | |
| Phase I/II Cabazitaxel for Recurrent Malignant Glioma | NCT01740570 | Brain Cancer | Cabazitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I | NCT00671801 | Malignant Gliom... | Irinotecan Lenalidomide | 18 Years - | M.D. Anderson Cancer Center | |
| Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas | NCT02795364 | Glioma Anaplastic Olig... Glioblastomas (... | Structural Imag... Metabolic Image... | 18 Years - 70 Years | Huashan Hospital | |
| Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) | NCT01110876 | Brain Cancer Glioblastoma Mu... | Vorinostat Erlotinib Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
| Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA | NCT02800486 | Glioblastoma Anaplastic Astr... Anaplastic Olig... Glioma Brain Neoplasm Brain Cancer Brain Tumor Brain Tumor, Re... Brain Neoplasm,... | Intra-arterial ... Intra-arterial ... Hypofractionate... | 18 Years - | Northwell Health | |
| Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) | NCT00671970 | Glioblastoma Gliosarcoma | Bevacizumab and... | 18 Years - | Duke University | |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma | NCT01656980 | Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma | Carmustine tumor resection... | 18 Years - 70 Years | Shandong Lanjin Pharmaceuticals Co.,Ltd | |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma | NCT01656980 | Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma | Carmustine tumor resection... | 18 Years - 70 Years | Shandong Lanjin Pharmaceuticals Co.,Ltd | |
| PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas | NCT00612651 | Gliosarcoma Glioblastoma Anaplastic Astr... | Temodar and SCH... | 18 Years - | Duke University | |
| BIBF 1120 for Recurrent High-Grade Gliomas | NCT01380782 | Glioblastoma Gliosarcoma Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | BIBF 1120 | 18 Years - | Dana-Farber Cancer Institute | |
| A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme | NCT05600491 | Anaplastic Olig... Glioblastoma | Temozolomide | 18 Years - 70 Years | Sun Yat-sen University | |
| Sorafenib in Newly Diagnosed High Grade Glioma | NCT00884416 | Glioblastoma Gliosarcoma Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | Sorafenib dose ... | 18 Years - | University Hospital, Geneva | |
| A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma | NCT00389090 | Glioma Astrocytoma Oligodendroglio... Oligoastrocytom... | Temozolomide an... | 18 Years - | Keryx / AOI Pharmaceuticals, Inc. | |
| Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma | NCT01189266 | Anaplastic Astr... Anaplastic Olig... Diffuse Intrins... Gliosarcoma | 3-Dimensional C... Intensity-Modul... Laboratory Biom... Vorinostat | 37 Months - 21 Years | National Cancer Institute (NCI) | |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma | NCT01637753 | Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma | Carmustine(BCNU... Surgery | 18 Years - 70 Years | Shandong Lanjin Pharmaceuticals Co.,Ltd | |
| Phase I/II Cabazitaxel for Recurrent Malignant Glioma | NCT01740570 | Brain Cancer | Cabazitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas | NCT01922076 | Anaplastic Astr... Anaplastic Olig... Diffuse Intrins... Diffuse Midline... Glioblastoma Gliosarcoma | Adavosertib Laboratory Biom... Pharmacological... Radiation Thera... | 37 Months - 21 Years | National Cancer Institute (NCI) | |
| Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas | NCT02015819 | Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Recurrent Adult... Anaplastic Olig... | E. coli CD-expr... flucytosine leucovorin calc... pharmacological... laboratory biom... | 18 Years - | City of Hope Medical Center | |
| Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor | NCT01470794 | Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | Toca 511 vector Toca FC | 18 Years - 80 Years | Tocagen Inc. | |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma | NCT01637753 | Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma | Carmustine(BCNU... Surgery | 18 Years - 70 Years | Shandong Lanjin Pharmaceuticals Co.,Ltd | |
| Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial | NCT01847235 | Anaplastic Olig... Anaplastic Olig... | Temozolomide | 20 Years - | Seoul National University Hospital | |
| Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial | NCT01847235 | Anaplastic Olig... Anaplastic Olig... | Temozolomide | 20 Years - | Seoul National University Hospital | |
| Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial | NCT01847235 | Anaplastic Olig... Anaplastic Olig... | Temozolomide | 20 Years - | Seoul National University Hospital | |
| A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma | NCT02026271 | Glioblastoma Mu... Anaplastic Olig... | Ad-RTS-hIL-12 veledimex | 18 Years - 75 Years | Alaunos Therapeutics | |
| Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas | NCT01966809 | Brain Tumor, Re... | Photofrin photo... | 18 Years - | Medical College of Wisconsin | |
| Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor | NCT01985256 | Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | Toca 511 Toca FC | 18 Years - 80 Years | Tocagen Inc. | |
| A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas | NCT02629757 | Anaplastic Olig... Anaplastic Astr... Glioblastoma | β-elemene | 18 Years - 75 Years | Sun Yat-sen University | |
| A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas | NCT01765088 | Anaplastic Olig... Anaplastic Astr... Glioblastoma | Temozolomide α-IFN | 18 Years - 75 Years | Sun Yat-sen University | |
| Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors | NCT00303849 | Anaplastic Olig... Anaplastic Olig... Mixed Glioma Oligoastrocytom... | Carboplatin Etoposide Etoposide Phosp... Laboratory Biom... Mannitol Melphalan Quality-of-Life... Sodium Thiosulf... | 18 Years - 75 Years | OHSU Knight Cancer Institute | |
| Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) | NCT00671970 | Glioblastoma Gliosarcoma | Bevacizumab and... | 18 Years - | Duke University | |
| A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 | NCT04327011 | Glioblastoma Mu... Astrocytoma Gliomas, Malign... | Toca 511 vector Toca FC • Flucy... | 18 Years - | Tocagen Inc. | |
| Ph I SU011248 + Irinotecan in Treatment of Pts w MG | NCT00611728 | Glioblastoma | SU011248 & Irin... | 18 Years - | Duke University | |
| Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas | NCT04623931 | Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Diffuse Astrocy... Glioblastoma Oligoastrocytom... Oligodendroglio... WHO Grade II Gl... WHO Grade III G... | Quality-of-Life... Questionnaire A... Radiation Thera... Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
| Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas | NCT01721577 | Glioblastoma Gliosarcoma Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Anaplastic Epen... | AXL1717 | 18 Years - | Rush University Medical Center | |
| Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) | NCT00671970 | Glioblastoma Gliosarcoma | Bevacizumab and... | 18 Years - | Duke University | |
| Re-irradiation of High Grade Gliomas: a Quality of Life Study | NCT01711580 | Anaplastic Astr... Glioblastoma Mu... Anaplastic Olig... | EORTC QLQ-C30 EORTC QLQ-BN20 Hopkins Verbal ... Stroop color-wo... Controlled oral... Jamar hand dyna... EORTC QLQ- FA13 Trail Making Te... | 18 Years - | Maastricht Radiation Oncology | |
| Sorafenib in Newly Diagnosed High Grade Glioma | NCT00884416 | Glioblastoma Gliosarcoma Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | Sorafenib dose ... | 18 Years - | University Hospital, Geneva | |
| A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma | NCT00389090 | Glioma Astrocytoma Oligodendroglio... Oligoastrocytom... | Temozolomide an... | 18 Years - | Keryx / AOI Pharmaceuticals, Inc. | |
| Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA | NCT02800486 | Glioblastoma Anaplastic Astr... Anaplastic Olig... Glioma Brain Neoplasm Brain Cancer Brain Tumor Brain Tumor, Re... Brain Neoplasm,... | Intra-arterial ... Intra-arterial ... Hypofractionate... | 18 Years - | Northwell Health | |
| Re-irradiation of High Grade Gliomas: a Quality of Life Study | NCT01711580 | Anaplastic Astr... Glioblastoma Mu... Anaplastic Olig... | EORTC QLQ-C30 EORTC QLQ-BN20 Hopkins Verbal ... Stroop color-wo... Controlled oral... Jamar hand dyna... EORTC QLQ- FA13 Trail Making Te... | 18 Years - | Maastricht Radiation Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
